All Posts

Eliminating Cholera transmission in Haiti

On October 13th and 14th, 2016, the Minister of Health and Population of Haiti, Dr. Daphnee Benoit, convened an expert panel to consult on the control of cholera in Haiti with specific reference to the use of vaccines in the aftermath of Hurricane Mathew; the consultation resulted in the following consensus.

UF to receive nearly $10 million to support new agricultural safety and health center

The University of Florida has received a grant of nearly $10 million from the Centers for Disease Control and Prevention through the National Institute of Occupational Safety and Health, or NIOSH, for a five-year project to explore the occupational safety and health of people working in agriculture, fishing and forestry in Florida, Georgia, Alabama, Mississippi and North and South Carolina.

Cameroon’s cholera outbreaks vary by climate region

For more than four decades, cholera has recurred in Cameroon, affecting tens of thousands of people a year. Most recently, the West African country was one of four that had a death rate of more than five percent from the bacterial disease, exceeding the World Health Organization’s target of less than one percent. Now, researchers have discovered one reason Cameroon has struggled to control the disease. Cholera follows different, distinct outbreak patterns in different climate subzones of the large country, the researchers reported in PLOS Neglected Tropical Diseases.

KC Jeong finds biological treatment for cow disease; could help humans, too

A UF/IFAS researcher and his colleagues are far more certain now that a new biological treatment could prevent dairy cattle from getting uterine diseases, which might improve food safety for people. Their findings, in which they used chitosan microparticles to cure bacteria in the uteri, are published in a new study.

Biostat researchers discuss roles in ongoing Ebola vaccine trial

when the Ebola crisis in West Africa began capturing the world’s attention, UF biostatistics professor Ira Longini has been collaborating with a team of scientists at the World Health Organization (WHO) to develop a vaccine capable of protecting the most at-risk populations from the disease.